Skip to content

Clinical trials

Carcinoma, Renal Cell trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Country / region: Australia Clear all

124 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20042
20053
20066
20072
20083
20091
20101
20112
20125
20131
20142
20153
20167
201714
20188
20197
202010
20219
20227
20238
20243
20257
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58
Active, not recruiting22
Recruiting20
Terminated14
Unknown status6
No longer available2
Not yet recruiting1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC13
Pfizer12
Novartis Pharmaceuticals10
Bristol-Myers Squibb8
GlaxoSmithKline6
Hoffmann-La Roche6
Exelixis5
Arcus Biosciences, Inc.3
AstraZeneca3
Australian and New Zealand Urogenital and Prostate Cancer Trials Group3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell124
Carcinoma, Non-Small-Cell Lung33
Melanoma27
Kidney Neoplasms23
Colorectal Neoplasms21
Squamous Cell Carcinoma of Head and Neck20
Ovarian Neoplasms19
Neoplasms16
Stomach Neoplasms16
Neoplasm Metastasis14

Trials

Showing 76 to 100 of 124. Each trial links to its page on Pharma Observatory.

24 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.